Literature DB >> 24048684

Clinical significance of microsatellite instability in colorectal cancer.

Matthias Kloor1, Laura Staffa, Aysel Ahadova, Magnus von Knebel Doeberitz.   

Abstract

INTRODUCTION: Colorectal cancer is a heterogeneous tumor type with regard to molecular pathogenesis and genetic instability. The majority of colorectal cancers display chromosomal instability and follow the classical adenoma-carcinoma sequence of tumor progression. A subset of about 15 % of colorectal cancers, however, displays DNA mismatch repair (MMR) deficiency and the high-level microsatellite instability (MSI-H) phenotype. MSI-H colorectal cancers can occur as sporadic tumors or in the context of hereditary non-polyposis colorectal cancer (HNPCC) or Lynch syndrome. CLINICAL RELEVANCE: The MSI-H phenotype is a hallmark of Lynch syndrome-associated cancers, which is of diagnostic relevance for the identification of Lynch syndrome mutation carriers. MSI-H colorectal cancers are characterized by a distinct clinical behavior, which results from their particular molecular pathogenesis and gives microsatellite instability testing its clinical significance. The MSI-H phenotype shows association with proximal tumor localization, a dense local lymphocyte infiltration, and a low frequency of distant organ metastasis. Moreover, MSI-H colorectal cancers have a better prognosis than their microsatellite-stable counterparts. A distinct responsiveness of MSI-H colorectal cancer patients towards chemotherapy has been shown in several studies.
CONCLUSIONS: The clinical characteristics of MSI-H cancers are closely linked to their molecular pathogenesis, and research on the molecular alteration characteristic of MSI-H cancers may provide the basis for novel diagnostic or therapeutic approaches.

Entities:  

Mesh:

Year:  2013        PMID: 24048684     DOI: 10.1007/s00423-013-1112-3

Source DB:  PubMed          Journal:  Langenbecks Arch Surg        ISSN: 1435-2443            Impact factor:   3.445


  64 in total

1.  Prophylactic surgery prevents endometrial and ovarian cancer in Lynch syndrome.

Authors:  Henry T Lynch; Murray Joseph Casey
Journal:  Nat Clin Pract Oncol       Date:  2007-10-30

2.  Comparison of extended colectomy and limited resection in patients with Lynch syndrome.

Authors:  Nagendra Natarajan; Patrice Watson; Edibaldo Silva-Lopez; Henry T Lynch
Journal:  Dis Colon Rectum       Date:  2010-01       Impact factor: 4.585

3.  Expression of a mutant HSP110 sensitizes colorectal cancer cells to chemotherapy and improves disease prognosis.

Authors:  Coralie Dorard; Aurélie de Thonel; Ada Collura; Laetitia Marisa; Magali Svrcek; Anaïs Lagrange; Gaetan Jego; Kristell Wanherdrick; Anne Laure Joly; Olivier Buhard; Jessica Gobbo; Virginie Penard-Lacronique; Habib Zouali; Emmanuel Tubacher; Sylvain Kirzin; Janick Selves; Gérard Milano; Marie-Christine Etienne-Grimaldi; Leila Bengrine-Lefèvre; Christophe Louvet; Christophe Tournigand; Jérémie H Lefèvre; Yann Parc; Emmanuel Tiret; Jean-François Fléjou; Marie-Pierre Gaub; Carmen Garrido; Alex Duval
Journal:  Nat Med       Date:  2011-09-25       Impact factor: 53.440

4.  High prevalence of activated intraepithelial cytotoxic T lymphocytes and increased neoplastic cell apoptosis in colorectal carcinomas with microsatellite instability.

Authors:  R Dolcetti; A Viel; C Doglioni; A Russo; M Guidoboni; E Capozzi; N Vecchiato; E Macrì; M Fornasarig; M Boiocchi
Journal:  Am J Pathol       Date:  1999-06       Impact factor: 4.307

5.  Adenoma prevalence and cancer risk in familial non-polyposis colorectal cancer.

Authors:  G Lindgren; A Liljegren; E Jaramillo; C Rubio; A Lindblom
Journal:  Gut       Date:  2002-02       Impact factor: 23.059

6.  Gynecologic cancer as a "sentinel cancer" for women with hereditary nonpolyposis colorectal cancer syndrome.

Authors:  Karen H Lu; Mai Dinh; Wendy Kohlmann; Patrice Watson; Jane Green; Sapna Syngal; Prathap Bandipalliam; Lee-May Chen; Brian Allen; Peggy Conrad; Jonathan Terdiman; Charlotte Sun; Molly Daniels; Thomas Burke; David M Gershenson; Henry Lynch; Patrick Lynch; Russell R Broaddus
Journal:  Obstet Gynecol       Date:  2005-03       Impact factor: 7.661

7.  Serum antibodies against frameshift peptides in microsatellite unstable colorectal cancer patients with Lynch syndrome.

Authors:  Miriam Reuschenbach; Matthias Kloor; Monika Morak; Nicolas Wentzensen; Anja Germann; Yvette Garbe; Mirjam Tariverdian; Peter Findeisen; Michael Neumaier; Elke Holinski-Feder; Magnus von Knebel Doeberitz
Journal:  Fam Cancer       Date:  2010-06       Impact factor: 2.375

Review 8.  Chemotherapy of MMR-deficient colorectal cancer.

Authors:  N Devaud; S Gallinger
Journal:  Fam Cancer       Date:  2013-06       Impact factor: 2.375

9.  Prognostic impact of β-2-microglobulin expression in colorectal cancers stratified by mismatch repair status.

Authors:  Viktor Hendrik Koelzer; Kristi Baker; Daniela Kassahn; Daniel Baumhoer; Inti Zlobec
Journal:  J Clin Pathol       Date:  2012-08-02       Impact factor: 3.411

10.  Microsatellite instability in colorectal cancer is associated with local lymphocyte infiltration and low frequency of distant metastases.

Authors:  A Buckowitz; H-P Knaebel; A Benner; H Bläker; J Gebert; P Kienle; M von Knebel Doeberitz; M Kloor
Journal:  Br J Cancer       Date:  2005-05-09       Impact factor: 7.640

View more
  28 in total

Review 1.  Phenotypic and genotypic heterogeneity of Lynch syndrome: a complex diagnostic challenge.

Authors:  Henry T Lynch; Stephen Lanspa; Trudy Shaw; Murray Joseph Casey; Marc Rendell; Mark Stacey; Theresa Townley; Carrie Snyder; Megan Hitchins; Joan Bailey-Wilson
Journal:  Fam Cancer       Date:  2018-07       Impact factor: 2.375

Review 2.  Adenomas - Genetic factors in colorectal cancer prevention.

Authors:  Kycler Witold; Kubiak Anna; Trojanowski Maciej; Janowski Jakub
Journal:  Rep Pract Oncol Radiother       Date:  2018-02-09

3.  Variable Levels of Long Noncoding RNA Expression in DNA Mismatch Repair-Proficient Early-Stage Colon Cancer.

Authors:  Qian Li; Nanshan Li; Yueqiong Lao; Wu Lin; Guojun Jiang; Nan Wei; Canghai Wang; Kuiliang Liu; Jing Wu
Journal:  Dig Dis Sci       Date:  2017-02-03       Impact factor: 3.199

Review 4.  Genetic and epigenetic biomarkers for diagnosis, prognosis and treatment of colorectal cancer.

Authors:  Fabio Coppedè; Angela Lopomo; Roberto Spisni; Lucia Migliore
Journal:  World J Gastroenterol       Date:  2014-01-28       Impact factor: 5.742

5.  Mismatch repair deficient-crypts in non-neoplastic colonic mucosa in Lynch syndrome: insights from an illustrative case.

Authors:  Jinru Shia; Zsofia K Stadler; Martin R Weiser; Efsevia Vakiani; Robin Mendelsohn; Arnold J Markowitz; Moshe Shike; C Richard Boland; David S Klimstra
Journal:  Fam Cancer       Date:  2015-03       Impact factor: 2.375

6.  Microsatellite instable vs stable colon carcinomas: analysis of tumour heterogeneity, inflammation and angiogenesis.

Authors:  L De Smedt; J Lemahieu; S Palmans; O Govaere; T Tousseyn; E Van Cutsem; H Prenen; S Tejpar; M Spaepen; G Matthijs; C Decaestecker; X Moles Lopez; P Demetter; I Salmon; X Sagaert
Journal:  Br J Cancer       Date:  2015-06-11       Impact factor: 7.640

7.  Epigenetics could explain some Moroccan population colorectal cancers peculiarities: microsatellite instability pathway exploration.

Authors:  Mohammed Sekal; Hassania Ameurtesse; Laila Chbani; Karim Ouldim; Sanae Bennis; Mohammed Abkari; Amal Boulouz; Dafr Allah Benajah; Basher Benjelloun; Abdelmalek Ousadden; Khalid Ait Taleb; Said Ait Laalim; Imane Toghrai; Khalid Mazaz; Samia Arifi; Nawfel Mellas; Karima El Rhazi; Taoufiq Harmouch; Sidi Adil Ibrahimi; Afaf Amarti Riffi
Journal:  Diagn Pathol       Date:  2015-06-24       Impact factor: 2.644

Review 8.  Clinical application of genetics in management of colorectal cancer.

Authors:  Eun Ran Kim; Young-Ho Kim
Journal:  Intest Res       Date:  2014-07-25

9.  Mlh1 heterozygosity and promoter methylation associates with microsatellite instability in mouse sperm.

Authors:  Kul S Shrestha; Minna M Tuominen; Liisa Kauppi
Journal:  Mutagenesis       Date:  2021-07-07       Impact factor: 3.000

10.  Clinicopathological Features and Survival of Signet-Ring Cell Carcinoma and Mucinous Adenocarcinoma of Right Colon, Left Colon, and Rectum.

Authors:  Lili Zhu; Chunrun Ling; Tao Xu; Jinglin Zhang; Yujie Zhang; Yingjie Liu; Chao Fang; Lie Yang; Wen Zhuang; Rui Wang; Jie Ping; Mojin Wang
Journal:  Pathol Oncol Res       Date:  2021-07-02       Impact factor: 3.201

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.